72 related articles for article (PubMed ID: 8867730)
1. Expanded glutamines and neurodegeneration--a gain of insight.
Bates G
Bioessays; 1996 Mar; 18(3):175-8. PubMed ID: 8867730
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.
Burke JR; Enghild JJ; Martin ME; Jou YS; Myers RM; Roses AD; Vance JM; Strittmatter WJ
Nat Med; 1996 Mar; 2(3):347-50. PubMed ID: 8612237
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.
Trottier Y; Lutz Y; Stevanin G; Imbert G; Devys D; Cancel G; Saudou F; Weber C; David G; Tora L
Nature; 1995 Nov; 378(6555):403-6. PubMed ID: 7477379
[TBL] [Abstract][Full Text] [Related]
4. Glutamine repeats: structural hypotheses and neurodegeneration.
Masino L; Pastore A
Biochem Soc Trans; 2002 Aug; 30(4):548-51. PubMed ID: 12196134
[TBL] [Abstract][Full Text] [Related]
5. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.
Szebenyi G; Morfini GA; Babcock A; Gould M; Selkoe K; Stenoien DL; Young M; Faber PW; MacDonald ME; McPhaul MJ; Brady ST
Neuron; 2003 Sep; 40(1):41-52. PubMed ID: 14527432
[TBL] [Abstract][Full Text] [Related]
6. Trinucleotide repeat expansion in neurological disease.
La Spada AR; Paulson HL; Fischbeck KH
Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766
[TBL] [Abstract][Full Text] [Related]
7. Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease.
Charrin BC; Saudou F; Humbert S
Pathol Biol (Paris); 2005 May; 53(4):189-92. PubMed ID: 15850950
[No Abstract] [Full Text] [Related]
8. Differential distribution of the normal and mutated forms of huntingtin in the human brain.
Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel JL; Hirsch EC
Ann Neurol; 1997 Nov; 42(5):712-9. PubMed ID: 9392570
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
Preisinger E; Jordan BM; Kazantsev A; Housman D
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
[TBL] [Abstract][Full Text] [Related]
10. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
11. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
Singhrao SK; Thomas P; Wood JD; MacMillan JC; Neal JW; Harper PS; Jones AL
Exp Neurol; 1998 Apr; 150(2):213-22. PubMed ID: 9527890
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of triplet repeats: unstable expansion of triplet repeats as a new mechanism for neurodegenerative diseases.
Tsuji S
Intern Med; 1997 Jan; 36(1):3-8. PubMed ID: 9058092
[TBL] [Abstract][Full Text] [Related]
13. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
[TBL] [Abstract][Full Text] [Related]
14. Etiology of (CAG)n triplet repeat neurodegenerative diseases such as Huntington's disease is connected to stimulation of glutamate receptors.
Fischer KM
Med Hypotheses; 1997 May; 48(5):393-8. PubMed ID: 9185124
[TBL] [Abstract][Full Text] [Related]
15. Trinucleotide repeats: mechanisms and pathophysiology.
Cummings CJ; Zoghbi HY
Annu Rev Genomics Hum Genet; 2000; 1():281-328. PubMed ID: 11701632
[TBL] [Abstract][Full Text] [Related]
16. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
[TBL] [Abstract][Full Text] [Related]
17. Gain of glutamines, gain of function?
Housman D
Nat Genet; 1995 May; 10(1):3-4. PubMed ID: 7647786
[No Abstract] [Full Text] [Related]
18. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
Suzuki Y; Jin C; Yazawa I
Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions.
Bates GP; Davies SW
Mol Med Today; 1997 Nov; 3(11):508-15. PubMed ID: 9430787
[TBL] [Abstract][Full Text] [Related]
20. Trinucleotide-repeat expansions and neurodegenerative disease: a mechanism of pathogenesis.
Hannan AJ
Clin Exp Pharmacol Physiol; 1996 Dec; 23(12):1015-20. PubMed ID: 8977152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
